The use of recombinant factor VIIa in a Jehovah's Witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage [12]

British Journal of Haematology

Volumn 119, Issue 1, 2002, Pages 286-288

  Waddington, Dominic P ^a   McAuley, Frank T ^b   Hanley, John P ^c   Summerfield, Geoffrey P ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Auto immune thrombocytopenia; Haemorrhage; Jehovah's Witness; Post splenectomy; Recombinant FVIIa

Indexed keywords

CYANOCOBALAMIN; ERYTHROPOIETIN; FOLIC ACID; IMMUNOGLOBULIN; IRON DERIVATIVE; METHYLPREDNISOLONE; PREDNISOLONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

AGED; AUTOIMMUNE DISEASE; BLOOD CLOTTING TEST; BLOOD TRANSFUSION; BONE MARROW EXAMINATION; CASE REPORT; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; DOSE RESPONSE; DRUG USE; FEMALE; HEMOGLOBIN DETERMINATION; HUMAN; IDIOPATHIC THROMBOCYTOPENIC PURPURA; LETTER; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RELIGIOUS GROUP; SPLENECTOMY; THROMBOCYTE COUNT;

AGED; AUTOIMMUNE DISEASES; FACTOR VIIA; FEMALE; HUMANS; JEHOVAH'S WITNESSES; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS; SPLENECTOMY; THROMBOCYTOPENIA;

EID: 0036400234     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.381113.x     Document Type: Letter

References (7)

1. Doyle, D.J. (2001) Hemoglobin-based blood substitutes for Jehovah's Witnesses. Journal of Clinical Anesthesiology, 13, 472.
2. Kenet, G., Walden, R., Eldad, A. & Martinowitz, U. (1999) Treatment of traumatic bleeding with recombinant factor VIIa. Lancet, 354, 1879.
3. Koestner, J.A., Nelson, L.D., Morris, Jr, J.A. & Safcsak, K. (1990) Use of recombinant human erythropoietin (R-HuEPO) in a Jehovah's Witness patient refusing transfusion of blood products: case report. Journal of Trauma-Injury Infection and Critical Care, 30, 1406-1408.
4. Majumdar, G. & Savidge, G.F. (1993) Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors. Blood Coagulation and Fibrinolysis, 4, 1031-1033.
5. Marelli, T.R. (1994) Use of a hemoglobin substitute in the anemic Jehovah's Witness patient. Critical Care Nurse, 14, 31-38.
6. Martinowitz, U., Kenet, G., Segal, E., Luboshitz, J., Lubetsky, A., Ingerslev, J. & Lynn, M. (2001) Recombinant activated factor VII for adjunctive hemorrhage control in trauma. Journal of Trauma-Injury Infection and Critical Care, 51, 431-438.
7. Papatheodoridis, G.V., Chung, S., Keshav, S., Pasi, J. & Burroughs, A.K. (1999) Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular carcinoma in liver cirrhosis. Journal of Hepatology, 31, 747-750.